Compaq Exec Says Alpha Phase-Out Won t Impact Life Science Business | GenomeWeb

NEW YORK, July 5 - Compaq Computer's recent decision to sell its Alpha integrated circuit chip technology to Intel, and to eventually standardize on Intel's Itanium chip, "has been very warmly accepted by the life science market at large," said Lionel Binns, worldwide life and materials science group manager for high-performance technical computing at Compaq. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.